loadpatents
name:-0.044803857803345
name:-0.0034871101379395
name:-0.00049185752868652
Brunner; Nils Patent Filings

Brunner; Nils

Patent Applications and Registrations

Patent applications and USPTO patent grants for Brunner; Nils.The latest application filed is for "tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer".

Company Profile
0.3.12
  • Brunner; Nils - Hellerup DK
  • Brunner; Nils - Hellerip DK
  • Brunner, Nils - Virum DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker And Postoperative Marker For Minimal Residual Disease Or Recurrent Disease In Patients With A Prior History Of Cancer
App 20110294148 - Holten-Andersen; Mads Nikolaj ;   et al.
2011-12-01
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker
App 20110060529 - Holten-Andersen; Mads ;   et al.
2011-03-10
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
Grant 7,807,379 - Holten-Andersen , et al. October 5, 2
2010-10-05
Method For Detecting, Screening, And/or Monitoring Cancer In An Individual
App 20090035794 - Hessel; Lasse L. ;   et al.
2009-02-05
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker And Postoperative Marker For Minimal Residual Disease Or Recurrent Disease In Patients With A Prior History Of Cancer
App 20080261246 - Holten-Andersen; Mads Nikolaj ;   et al.
2008-10-23
Inhibition of invasive remodelling
App 20080171691 - Lund; Leif Roge ;   et al.
2008-07-17
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
Grant 7,374,886 - Holten-Andersen , et al. May 20, 2
2008-05-20
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
App 20070020707 - Holten-Andersen; Mads ;   et al.
2007-01-25
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
Grant 7,108,983 - Holten-Andersen , et al. September 19, 2
2006-09-19
Method for detecting, screening and/or montoring a cancer in individual
App 20060154245 - Hessel; Lasse L. ;   et al.
2006-07-13
Method for detecting, screening and/or monitoring a cancer in an individual
App 20060014224 - Brunner; Nils ;   et al.
2006-01-19
Inhibition of invasive remodelling
App 20050137121 - Lund, Leif Roge ;   et al.
2005-06-23
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
App 20030082652 - Holten-Andersen, Mads Nikolaj ;   et al.
2003-05-01
Inhibition of invasive remodelling
App 20020099004 - Lund, Leif Roge ;   et al.
2002-07-25
Pai-1 determination and use thereof
App 20020012950 - Nielsen, Lars S. ;   et al.
2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed